Literature DB >> 8380356

Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.

J D Roberts1, T Y Chen, N Kawai, J Wain, P Dupuy, A Shimouchi, K Bloch, D Polaner, W M Zapol.   

Abstract

We determined whether inhaling low levels of nitric oxide (NO) gas could selectively reverse hypoxic pulmonary vasoconstriction in the near-term newborn lamb and whether vasodilation would be attenuated by respiratory acidosis. To examine the mechanism of air and NO-induced pulmonary vasodilation soon after birth, we measured plasma and lung cGMP levels in the newly ventilated fetal lamb. Breathing at FIO2 0.10 nearly doubled the pulmonary vascular resistance index in newborn lambs and decreased pulmonary blood flow primarily by reducing left-to-right blood flow through the ductus arteriosus. Inhaling 20 ppm NO at FIO2 0.10 completely reversed hypoxic pulmonary vasoconstriction within minutes. Maximum pulmonary vasodilation occurred during inhalation of > or = 80 ppm NO. Breathing 8% CO2 at FIO2 0.10 elevated the pulmonary vascular resistance index to a level similar to breathing at FIO2 0.10 without added CO2. Respiratory acidosis did not attenuate pulmonary vasodilation by inhaled NO. In none of our studies did inhaling NO produce systemic hypotension or elevate methemoglobin levels. Four minutes after initiating ventilation with air in the fetal lamb lung, cGMP concentration nearly doubled without changing preductal plasma cGMP concentration. Ventilation with 80 ppm NO at FIO2 0.21 increased both lung and preductal plasma cGMP concentration threefold. Our data suggest that inhaled NO gas is a rapid and potent selective vasodilator of the newborn pulmonary circulation with an elevated vascular tone due to hypoxia and respiratory acidosis that acts by increasing lung cGMP concentration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380356     DOI: 10.1161/01.res.72.2.246

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  16 in total

1.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

2.  Additional considerations for inhaled nitric oxide therapy in congenital diaphragmatic hernia.

Authors:  M S Irish; P Kapur; P L Glick
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

3.  Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling.

Authors:  Lili Du; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

4.  Minidose inhaled nitric oxide: less is better.

Authors:  W M Zapol
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 5.  Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.

Authors:  J P Kovalchin; A R Mott; K L Rosen; T F Feltes
Journal:  Tex Heart Inst J       Date:  1997

Review 6.  Nitric oxide for respiratory failure in infants born at or near term.

Authors:  Keith J Barrington; Neil Finer; Thomas Pennaforte; Gabriel Altit
Journal:  Cochrane Database Syst Rev       Date:  2017-01-05

7.  Responses of the post-term arterial duct to oxygen, prostaglandin E2, and the nitric oxide donor, 3-morpholinosydnonimine, in lambs and their clinical implications.

Authors:  S E Abrams; K P Walsh; S J Coker; M J Clarkson
Journal:  Br Heart J       Date:  1995-02

8.  Inhaled nitric oxide in acute respiratory failure: dose-response curves.

Authors:  L Puybasset; J J Rouby; E Mourgeon; T E Stewart; P Cluzel; M Arthaud; P Poète; L Bodin; A M Korinek; P Viars
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

9.  Inhaled cigarette smoke selectively reverses human hypoxic vasoconstriction.

Authors:  P M Dupuy; J P Lançon; M Françoise; C G Frostell
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

10.  IL-1β dysregulates cGMP signaling in the newborn lung.

Authors:  Ying Zhong; Kristina Bry; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-06       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.